The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Genetic Spectrum and Clinical Correlates of Somatic Mutations in Aldosterone-Producing Adenoma
Open accessAbstract
Primary aldosteronism is the most common form of secondary hypertension. Somatic mutations in KCNJ5, ATP1A1, ATP2B3, and CACNA1D have been described in aldosterone-producing adenomas (APAs). Our aim was to investigate the prevalence of somatic mutations in these genes in unselected patients with APA (n=474), collected through the European Network for the Study of Adrenal Tumors. Correlations with clinical and biochemical parameters were first analyzed in a subset of 199 patients from a single center and then replicated in 2 additional centers. Somatic heterozygous KCNJ5 mutations were present in 38% (180/474) of APAs, whereas ATP1A1 mutations were found in 5.3% (25/474) and ATP2B3 mutations in 1.7% (8/474) of APAs. Previously reported somatic CACNA1D mutations as well as 10 novel CACNA1D mutations were identified in 44 of 474 (9.3%) APAs. There was no difference in the cellular composition of APAs or in CYP11B2, CYP11B1, KCNJ5, CACNA1D, or ATP1A1 gene expression in APAs across genotypes. Patients with KCNJ5 mutations were more frequently female, diagnosed younger, and with higher minimal plasma potassium concentrations compared with CACNA1D mutation carriers or noncarriers. CACNA1D mutations were associated with smaller adenomas. These associations were largely dependent on the population structure of the different centers. In conclusion, recurrent somatic mutations were identified in 54% of APAs. Young women with APAs are more likely to be KCNJ5 mutation carriers; identification of specific characteristics or surrogate biomarkers of mutation status may lead to targeted treatment options.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
Self-citationA prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Self-citationK + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
Choi, M., Scholl, U. I., Yue, P., Björklund, P., Zhao, B., Nelson-Williams, C. J., Ji, W., Cho, Y., Patel, A. P., Men, C. J., et al. (2011) · Science · doi:10.1126/science.1198785 · Cited by 999
Mulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
Self-citationPitt, B., Wj, R., Zannad, F. M., Neaton, J. D., Martínez, F. A., Roniker, B., Bittman, R. M., Hurley, S., Kleiman, J. H., & Gatlin, M. R. (2003) · Cited by 708
Scholl, U. I., Goh, G., Stölting, G., de Oliveira, R. C., Choi, M., Overton, J. D., Fonseca, A. L., Korah, R., Starker, L. F., Kunstman, J. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2695 · Cited by 627
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577
Self-citationSomatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension
Azizan, E. A. B., Poulsen, H., Tuluc, P., Zhou, J., Clausen, M. V., Lieb, A., Maniero, C., Garg, S., Bochukova, E. G., Zhao, W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2716 · Cited by 544
Cited by
Sorted by citations
Items 101–200 of 308
Genetics of primary hyperaldosteronism
Dutta, R. K., Söderkvist, P., & Gimm, O. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0055 · Cited by 36
Classification of microadenomas in patients with primary aldosteronism by steroid profiling
Yang, Y., Burrello, J., Burrello, A., Eisenhofer, G., Peitzsch, M., Tetti, M., Knösel, T., Beuschlein, F., Lenders, J. W. M., Mulatero, P., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.01.008 · Cited by 34
Self-citationBarrett, P. Q., Guagliardo, N. A., Klein, P., Hu, C., Breault, D. T., & Beenhakker, M. P. (2016) · The Journal of Physiology · doi:10.1113/jp271896 · Cited by 34
Tamura, A., Nishimoto, K., Seki, T., Matsuzawa, Y., Saito, J., Omura, M., Gómez-Sánchez, C. E., Makita, K., Matsui, S., Moriya, N., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.031 · Cited by 33
Yamazaki, Y., Omata, K., Tezuka, Y., Ono, Y., Morimoto, R., Adachi, Y., Ise, K., Nakamura, Y., Gómez-Sánchez, C. E., Shibahara, Y., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.10907 · Cited by 33
Inoue, K., Yamazaki, Y., Kitamoto, T., Hirose, R., Saito, J., Omura, M., Sasano, H., & Nishikawa, T. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00738 · Cited by 32
Ion Transporters, Channelopathies, and Glucose Disorders
Demirbilek, H., Galcheva, S., Vurallı, D., Al‐Khawaga, S., & Hussain, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102590 · Cited by 33
Evaluation and Management of Primary Hyperaldosteronism
Lee, F. T., & Elaraj, D. M. (2019) · Surgical Clinics of North America · doi:10.1016/j.suc.2019.04.010 · Cited by 32
Circulating miRNA Expression Profiling in Primary Aldosteronism
Decmann, Á., Nyírő, G., Darvasi, O., Turai, P. I., Bancos, I., Kaur, R. J., Pezzani, R., Iacobone, M., Kraljević, I., Kaštelan, D., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00739 · Cited by 32
Self-citationGuo, Z., Nanba, K., Udager, A. M., McWhinney, B. C., Ungerer, J. P. J., Wolley, M. J., Thuzar, M., Gordon, R. D., Rainey, W. E., & Stowasser, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa367 · Cited by 32
The molecular basis of primary aldosteronism: from chimeric gene to channelopathy
Lenzini, L., & Rossi, G. P. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.12.005 · Cited by 31
Athimulam, S., Lazik, N., & Bancos, I. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.08.003 · Cited by 31
Local Control of Aldosterone Production and Primary Aldosteronism
Lalli, E., Barhanin, J., Zennaro, M., & Warth, R. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.01.003 · Cited by 30
Self-citationThe human adrenal cortex: growth control and disorders
Lotfi, C. F. P., Kremer, J. L., Passaia, B. D. S., & Cavalcante, I. P. (2018) · Clinics · doi:10.6061/clinics/2018/e473s · Cited by 31
Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism
Weigel, M., Riester, A., Hanslik, G., Lang, K., Willenberg, H. S., Endres, S., Allolio, B., Beuschlein, F., Reincke, M., & Quinkler, M. O. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1013 · Cited by 30
Self-citationSydorchuk, L., Dzhuriak, V., Sydorchuk, A., Levytska, S. А., Petrynych, V. V., Кнут, Р. П., Kshanovska, A., Iftoda, O., Ткачук, О. В., Kyfiak, P., et al. (2020) · Endocrine Regulations · doi:10.2478/enr-2020-0024 · Cited by 31
Chang, Y., Tsai, C., Peng, S., Chen, Z., Chang, C., Lee, B., Liao, C., Pan, C., Chen, Y., Lin, L., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15679 · Cited by 29
Fallo, F., Castellano, I., Gómez-Sánchez, C. E., Rhayem, Y., Pilon, C., Vicennati, V., Santini, D., Maffeis, V., Fassina, A., Mulatero, P., et al. (2017) · Endocrine · doi:10.1007/s12020-017-1295-4 · Cited by 29
Self-citationPathogenesis of Familial Hyperaldosteronism Type II: New Concepts Involving Anion Channels
Stowasser, M., Wolley, M. J., Wu, A., Gordon, R. D., Schewe, J., Stölting, G., & Scholl, U. I. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0934-y · Cited by 29
Deinum, J., Prejbisz, A., Lenders, J. W. M., & van der Wilt, G. J. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09294 · Cited by 29
Urine steroid metabolomics as a diagnostic tool in primary aldosteronism
Prete, A., Lang, K., Pavlov, D., Rhayem, Y., Sitch, A. J., Franke, A. S., Gilligan, L. C., Shackleton, C. H. L., Hahner, S., Quinkler, M. O., et al. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106445 · Cited by 27
Self-citationThe spectrum of low-renin hypertension
Buffolo, F., Monticone, S., Pecori, A., Pieroni, J., Losano, I., Cavaglià, G., Tetti, M., Veglio, F., & Mulatero, P. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101399 · Cited by 27
Self-citationNew advances in endocrine hypertension: from genes to biomarkers
Fernandes-Rosa, F. L., Boulkroun, S., Fedlaoui, B., Hureaux, M., Travers, S. A. A., Drossart, T., Favier, J., & Zennaro, M. (2023) · Kidney International · doi:10.1016/j.kint.2022.12.021 · Cited by 28
Self-citationFrom Theory to Reality: Establishing a Successful Kidney Genetics Clinic in the Outpatient Setting
Lundquist, A. L., Pelletier, R. C., Leonard, C. E., Williams, W. W., Armstrong, K., Rehm, H. L., & Rhee, E. P. (2020) · Kidney360 · doi:10.34067/kid.0004262020 · Cited by 27
On the effect of hyperaldosteronism-inducing mutations in Na/K pumps
Meyer, D. J., Gatto, C., & Artigas, P. (2017) · The Journal of General Physiology · doi:10.1085/jgp.201711827 · Cited by 26
Genetic and Histopathologic Intertumor Heterogeneity in Primary Aldosteronism
Omata, K., Yamazaki, Y., Nakamura, Y., Anand, S. K., Barletta, J. A., Sasano, H., Rainey, W. E., Tomlins, S. A., & Vaidya, A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-4007 · Cited by 25
Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations
Lim, J. S., Plaska, S. W., Rege, J., Rainey, W. E., & Turcu, A. F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.644382 · Cited by 25
Functional histopathological markers of aldosterone producing adenoma and somatic KCNJ5 mutations
Fernandes-Rosa, F. L., Amar, L., Tissier, F., Bertherat, J. Y., Méatchi, T., Zennaro, M., & Boulkroun, S. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.020 · Cited by 25
Self-citationMolecular characteristics of the KCNJ5 mutated aldosterone-producing adenomas
Murakami, M., Yoshimoto, T., Nakabayashi, K., Nakano, Y., Fukaishi, T., Tsuchiya, K., Minami, I., Bouchi, R., Okamura, K., Fujii, Y., et al. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0117 · Cited by 25
Molecular and Cellular Mechanisms of Aldosterone Producing Adenoma Development
Boulkroun, S., Fernandes-Rosa, F. L., & Zennaro, M. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00095 · Cited by 24
Self-citationInoue, K., Kitamoto, T., Tsurutani, Y., Saito, J., Omura, M., & Nishikawa, T. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.645488 · Cited by 26
Update on Genetics of Primary Aldosteronism
Itcho, K., Oki, K., Ohno, H., & Yoneda, M. (2021) · Biomedicines · doi:10.3390/biomedicines9040409 · Cited by 24
Gender differences in human adrenal cortex and its disorders
Gao, X., Yamazaki, Y., Tezuka, Y., Omata, K., Ono, Y., Morimoto, R., Nakamura, Y., Satoh, F., & Sasano, H. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111177 · Cited by 23
Histopathology and Genetic Causes of Primary Aldosteronism in Young Adults
Nanba, K., Baker, J. E., Blinder, A., Bick, N. R., Liu, C., Lim, J. S., Wachtel, H., Cohen, D. L., Williams, T. A., Reincke, M., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac408 · Cited by 23
Self-citationNovel genetic determinants of adrenal aldosterone regulation
Azizan, E. A. B. A., & Brown, M. J. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000255 · Cited by 22
Of channels and pumps: different ways to boost the aldosterone?
Bandulik, S. (2016) · Acta Physiologica · doi:10.1111/apha.12832 · Cited by 22
Regulation of aldosterone production by ion channels: From basal secretion to primary aldosteronism
Yang, T., He, M., & Hu, C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.12.034 · Cited by 22
Primary Aldosteronism in the Elderly
Mulatero, P., Burrello, J., Williams, T. A., & Monticone, S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa206 · Cited by 22
Self-citationPathology of Aldosterone Biosynthesis and its Action
Gao, X., Yamazaki, Y., Tezuka, Y., Omata, K., Ono, Y., Morimoto, R., Nakamura, Y., Suzuki, T., Satoh, F., & Sasano, H. (2021) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.254.1 · Cited by 22
Rege, J., Turcu, A. F., & Rainey, W. E. (2020) · Gland Surgery · doi:10.21037/gs.2019.10.22 · Cited by 22
Bilateral Idiopathic Adrenal Hyperplasia: Genetics and Beyond
Fernandes-Rosa, F. L., Boulkroun, S., Jeunemaı̂tre, X., & Zennaro, M. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565198 · Cited by 21
Self-citationExpression of aldosterone synthase CYP11B2 was inversely correlated with longevity
Hayashi, T., Zhang, Z., Al‐Eyd, G., Sasaki, A., Yasuda, M., Oyama, M., Gómez-Sánchez, C. E., Asakura, H., Seki, T., Mukai, K., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.04.010 · Cited by 21
Diverse Responses of Autoantibodies to the Angiotensin II Type 1 Receptor in Primary Aldosteronism
Williams, T. A., Jaquin, D., Burrello, J., Philippe, A., Yang, Y., Rank, P., Nirschl, N., Sturm, L., Hübener, C., Dragun, D., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13156 · Cited by 21
Self-citationGenetic Alterations in Benign Adrenal Tumors
Pitsava, G., & Stratakis, C. A. (2022) · Biomedicines · doi:10.3390/biomedicines10051041 · Cited by 20
Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome
de Santana, L. S., Guimaraes, A. G., & Almeida, M. Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.927669 · Cited by 21
Guagliardo, N. A., Yao, J., Stipes, E. J., Cechova, S., Le, T. H., Bayliss, D. A., Breault, D. T., & Barrett, P. Q. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.11962 · Cited by 20
Familial hyperaldosteronism type III a novel case and review of literature
Fernández, N. P., Moreno, F., Morata, J., Gutiérrez, A. M., León, S., Mingo, C. D., Zúñiga, Á., & Calvo, F. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9481-0 · Cited by 20
Cardiovascular and metabolic characters of KCNJ5 somatic mutations in primary aldosteronism
Chang, Y., Lee, B., Chen, Z., Tsai, C., Chang, C., Liao, C., Pan, C., Peng, K., Chou, C., Lu, C., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1061704 · Cited by 19
Immunohistochemistry of the adrenal in primary aldosteronism
Gómez-Sánchez, C. E., & Gómez-Sánchez, E. P. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000248 · Cited by 19
Kishimoto, R., Oki, K., Yoneda, M., Gómez-Sánchez, C. E., Ohno, H., Kobuke, K., Itcho, K., & Kohno, N. (2016) · Medicine · doi:10.1097/md.0000000000003659 · Cited by 19
KCNJ5 Mutations: Sex, Salt and Selection
Lenders, J. W. M., Burrello, J., Beuschlein, F., Reincke, M., & Williams, T. A. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565090 · Cited by 19
Self-citationOld and new genes in primary aldosteronism
Boulkroun, S., Fernandes-Rosa, F. L., & Zennaro, M. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101375 · Cited by 20
Self-citationZennaro, M., & Jeunemaı̂tre, X. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.02.006 · Cited by 19
Self-citationGenetics of adrenocortical tumours
Åkerström, T., Carling, T., Beuschlein, F., & Hellman, P. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12452 · Cited by 20
Self-citationThe Potential Role of Aldosterone-Producing Cell Clusters in Adrenal Disease
Lim, J. S., & Rainey, W. E. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1128-0421 · Cited by 18
Progress in the Management of Primary Aldosteronism
Morimoto, R., Omata, K., Ito, S., & Satoh, F. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy018 · Cited by 17
Nanba, K., Rainey, W. E., & Udager, A. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.683588 · Cited by 17
Wu, C., Peng, K., Hwang, D., Lin, Y., Wu, V., & Chueh, S. (2021) · Biomedicines · doi:10.3390/biomedicines9091167 · Cited by 20
CTNNB1Mutation in Aldosterone Producing Adenoma
Wang, J., Peng, K., Wu, V., Tseng, F., & Wu, K. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.3.332 · Cited by 17
Prevalence of Somatic KCNJ5 Mutations in Thai Patients With Aldosterone-Producing Adrenal Adenomas
Parksook, W. W., Atikankul, T., Houngngam, N., & Sunthornyothin, S. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00097 · Cited by 17
Somatic Mutations in MCOLN3 Are Associated With Aldosterone-Producing Adenomas
van Rooyen, D., Bandulik, S., Coon, G., Laukemper, M., Kumar‐Sinha, C., Udager, A. M., Lerário, A. M., Lee, C., Wachtel, H., Cohen, D. L., et al. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.24909 · Cited by 16
Unanswered Questions in the Genetic Basis of Primary Aldosteronism
Scholl, U. I. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-120066 · Cited by 16
Pang, Y., Gong, S., Tetti, M., Sun, Z., Mir-Bashiri, S., Bidlingmaier, M., Knösel, T., Wolf, E., Reincke, M., Kemter, E., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103498 · Cited by 15
Self-citationMineralocorticoid and Apparent Mineralocorticoid Syndromes of Secondary Hypertension
Ardhanari, S., Kannuswamy, R., Chaudhary, K. R., Lockette, W. E., & Whaley‐Connell, A. T. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2015.03.002 · Cited by 16
Pauzi, F. A., & Azizan, E. A. B. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.631848 · Cited by 16
The L‐type calcium channel CaV1.3: A potential target for cancer therapy
Liu, X., Shen, B., Zhou, J., Hao, J., & Wang, J. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70123 · Cited by 15
Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtype‐Specific Alterations
Lana, A., Alexander, K., Castagna, A., D’Alessandro, A., Morandini, F., Pizzolo, F., Zorzi, F., Mulatero, P., Zolla, L., & Olivieri, O. (2018) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201800049 · Cited by 15
Self-citationChen, K.-M., Chang, Y.-L., Wu, T.-H., Lee, B.-C., Chen, P.-T., Liu, K.-L., Hong, J.-S., Chang, C.-C., Wu, V.-C., & Lin, Y.-H. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002948 · Cited by 15
Lin, W., Gan, W., Feng, P., Zhong, L., Yao, Z., Chen, P., He, W., & Yu, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.882148 · Cited by 14
CACNA1D-Related Channelopathies: From Hypertension to Autism
Ortner, N. J. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2022_626 · Cited by 15
Hyperaldosteronism after decreased renal K+excretion in KCNMB2 knockout mice
Larsen, C. K., Jensen, I. S., Sørensen, M. V., de Bruijn, P. I. A., Bleich, M., Prætorius, H. A., & Leipziger, J. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00010.2016 · Cited by 15
Steroid Hormone Production in Patients with Aldosterone Producing Adenomas
Moors, M. L., Williams, T. A., Deinum, J., Eisenhofer, G., Reincke, M., & Lenders, J. W. M. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565225 · Cited by 14
Self-citationTranscriptomics, Epigenetics, and Metabolomics of Primary Aldosteronism
Spyroglou, A., Piaditis, G. P., Kaltsas, G., & Alexandraki, K. (2021) · Cancers · doi:10.3390/cancers13215582 · Cited by 14
Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism
Prada, E. T. A., Castellano, I., Sušnik, E., Yang, Y., Meyer, L. S., Tetti, M., Beuschlein, F., Reincke, M., & Williams, T. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041124 · Cited by 14
Self-citationZein, R. M. E., Soria, A. H., Dzib, J. F. G., Rickard, A. J., Fernandes-Rosa, F. L., Samson-Couterie, B., Giscos-Douriez, I., Rocha, A., Poglitsch, M., Gómez-Sánchez, C. E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50988-2 · Cited by 14
Self-citationBarrett, P. Q., Guagliardo, N. A., & Bayliss, D. A. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030220-113038 · Cited by 17
The Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 14
Pathophysiology of bilateral hyperaldosteronism
Nanba, K., & Rainey, W. E. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000729 · Cited by 15
Seidel, E., & Scholl, U. I. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00075 · Cited by 14
Disorders of the adrenal cortex: Genetic and molecular aspects
Pitsava, G., Maria, A. G., & Faucz, F. R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.931389 · Cited by 13
Zhou, T., Luo, P.-W., Wang, L., Yang, S., Qin, S., Wei, Z., & Liu, J. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820979685 · Cited by 13
Stanton, A. M., Heydarpour, M., Williams, J. S., Williams, G. H., & Adler, G. K. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21229 · Cited by 12
Chan, C., Yang, W., Lin, Y., Chang, C., Wu, V., & Chueh, S. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf007 · Cited by 11
Targeted disruption of the Kcnj5 gene in the female mouse lowers aldosterone levels
Hardege, I., Long, L., Maskari, R. A., Figg, N., & O’Shaughnessy, K. M. (2017) · Clinical Science · doi:10.1042/cs20171285 · Cited by 12
Molecular genetics of Conn adenomas in the era of exome analysis
Zein, R. M. E., Boulkroun, S., Fernandes-Rosa, F. L., & Zennaro, M. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.07.006 · Cited by 11
Self-citationRole of Cryptochrome-1 and Cryptochrome-2 in Aldosterone-Producing Adenomas and Adrenocortical Cells
Tetti, M., Castellano, I., Veneziano, F., Magnino, C., Veglio, F., Mulatero, P., & Monticone, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061675 · Cited by 11
Self-citationHattangady, N. G., Foster, J., Lerário, A. M., Ponce‐Balbuena, D., Rege, J., Monticone, S., Rainey, W. E., Mulatero, P., & Else, T. (2020) · Hormones and Cancer · doi:10.1007/s12672-019-00375-0 · Cited by 11
Self-citationGenetic and Potential Autoimmune Triggers of Primary Aldosteronism
Williams, T. A., Mulatero, P., Bidlingmaier, M., Beuschlein, F., & Reincke, M. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05643 · Cited by 11
Self-citationA Novel Somatic Mutation of CACNA1H p.V1937M in Unilateral Primary Hyperaldosteronism
Tseng, C., Peng, K., Wang, S., Tsai, Y., Huang, K., Lin, W., Hu, Y., Wu, V., & Chueh, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.816476 · Cited by 10
T- and L-Type Calcium Channels Maintain Calcium Oscillations in the Murine Zona Glomerulosa
Dinh, H. A., Volkert, M., Secener, K., Scholl, U. I., & Stölting, G. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.21798 · Cited by 10
Evaluating the role of aldosterone synthesis on adrenal cell fate
Aminuddin, A., Brown, M. J., & Azizan, E. A. B. A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1423027 · Cited by 10
Goldbaum, T. S., Ledesma, F. L., Guimaraes, A. G., Okubo, J., Kawahara, E. Z., Calsavara, V. F., Bortolotto, L. A., Chambo, J. L., Fragoso, M. C. B. V., Pereira, M. A. A., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf118 · Cited by 10
Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas
Pitsava, G., Faucz, F. R., Stratakis, C. A., & Hannah‐Shmouni, F. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01735-z · Cited by 10
Gao, X., Yamazaki, Y., Tezuka, Y., Omata, K., Ono, Y., Morimoto, R., Nakamura, Y., Satoh, F., & Sasano, H. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.101 · Cited by 10
Genetics improves understanding of adrenocortical tumours
BERTAGNA, X. Y. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.215 · Cited by 9
Chang, Y., Pan, C., Chen, Z., Tsai, C., Peng, S., Chang, C., Lee, B., Liao, C., Peng, K., Chiu, Y., et al. (2021) · Cancers · doi:10.3390/cancers13174313 · Cited by 9
Lee, B., Kang, V. J.-W., Pan, C., Huang, J.-Z., Lin, Y., Chang, Y., Tsai, C., Chou, C., Chen, Z., Liao, C., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.830130 · Cited by 9
Coexisting Prolactinoma and Primary Aldosteronism: Is There a Pathophysiological Link?
Williams, T. A., Dietz, A., Theodoropoulou, M., Riester, A., Fischer, E., Burrello, J., Treitl, M., Geyer, L. L., Veglio, F., Bidlingmaier, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2422 · Cited by 9
Self-citationSomatic mutations of the ATP1A1 gene and aldosterone-producing adenomas
Gómez-Sánchez, C. E., Kuppusamy, M., & Gómez-Sánchez, E. P. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.004 · Cited by 9
Mohideen, S. K., Mustangin, M., Kamaruddin, N. A., Muhammad, R., Jamal, A. R. A., Sukor, N., Tan, G. C., & Azizan, E. A. B. A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00666 · Cited by 10
Metadata
- Authors
- Fernandes-Rosa, F. L., Williams, T. A., Riester, A., Steichen, O., Beuschlein, F., Boulkroun, S., Strom, T. M., Monticone, S., Amar, L., Meatchi, T., Mantero, F., Cicala, M.-V., Quinkler, M., Fallo, F., Allolio, B., Bernini, G., Maccario, M., Giacchetti, G., Jeunemaitre, X., Mulatero, P., Reincke, M., & Zennaro, M.-C.
- Affiliations
- Inserm (FR)
- From the INSERM, UMRS_970, Paris Cardiovascular Research Center, Paris, France (F.L.F.-R., S.B., L.A., T.M., X.J., M.-C.Z.); University Paris Descartes, Sorbonne Paris Cité, Paris, France (F.L.F.-R., S.B., L.A., T.M., X.J., M.-C.Z.); Service de Génétique (F.L.F.-R., X.J., M.-C.Z.), Unité Hypertension artérielle (L.A.), and Service d’Anatomie Pathologique (T.M.), Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France; Divisions of Internal Medicine and Hypertension,...
- ORCID
- Venue
- Hypertension
- Published
- 2014-08
- Volume
- 64
- Issue
- 2
- Pages
- 354-361
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2111582520
- Cited by
- 310
- References
- 30
- Citations by year
- 2026: 21 · 2025: 18 · 2024: 14 · 2023: 15 · 2022: 16 · 2021: 28 · 2020: 27 · 2019: 33 · 2018: 25 · 2017: 31 · 2016: 34 · 2015: 33 · 2014: 12
- FWCI
- 29.40
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- aldosterone-producing adenoma, primary aldosteronism, somatic mutations, KCNJ5, ATP1A1, ATP2B3, CACNA1D, secondary hypertension, plasma potassium, adenoma size, mutation prevalence, genetic spectrum, clinical correlates
- MeSH terms
- Sodium-Potassium-Exchanging ATPase, Adrenal Cortex Neoplasms, Adult, Age Factors, Aldosterone, Female, Humans, Hyperaldosteronism, Male, Middle Aged, Mutation, Potassium, Sex Factors, Adrenocortical Adenoma, Genetic Predisposition to Disease, Calcium Channels, L-Type, G Protein-Coupled Inwardly-Rectifying Potassium Channels, Plasma Membrane Calcium-Transporting ATPases, Genetic Association Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review